Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Web – sheet or filament bases; compositions of bandages; or...
Reexamination Certificate
1999-08-25
2001-08-14
Page, Thurman K. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Web, sheet or filament bases; compositions of bandages; or...
C424S449000, C424S443000
Reexamination Certificate
active
06274165
ABSTRACT:
The invention relates to an active compound-containing patch for the controlled delivery of oestradiol or its pharmaceutically acceptable derivatives, alone or in combination with gestagens, to human or animal skin, having an active compound-containing reservoir based on ethylcellulose and contact adhesives comprising adhesive resins.
Transdermal therapeutic systems have been known for a relatively long time, in particular also for the transdermal administration of hormones, especially oestrogens, if appropriate in combination with gestagens.
The active compounds are provided for this in an active compound reservoir based on contact adhesives, whose adhesiveness must guarantee adequate skin contact on application without excessive softening and without skin irritation occurring, and whose absorption and release of active compound must conform to the desired continuous systemic supply of active compound through the skin.
As a basis for reservoir layers comprising oestradiol, inter alia, different materials based on rubber or polyacrylate, in particular comprising ethanol, have already been proposed (e.g. DE-A-32 05 258 and EP-0 275 716).
DE-A-39 33 460 describes active compound patches based on homo- and copolymers comprising at least one derivative of acrylic or methacrylic acid, which are additionally intended to contain water-swellable substances.
DE-B 40 20 144 discloses a transdermal system, optionally also containing hormone, comprising at least one self-adhesive active compound layer, which besides polyacrylate and a film-forming agent compatible therewith should contain a wide quantitative range of plasticizing active compounds and auxiliaries.
A recently described transdermal therapeutic system (see DE-A 195 00 662) comprises an active compound reservoir, containing an oestradiol and, if appropriate, gestagens, based on ethylcellulose having a high proportion of esters of optionally hydrogenated colophony as a tackifying resin together with up to 20% by weight of lauric acid, which is intended to counteract recrystallization of the active compound and thus a decrease in its release rate.
Surprisingly, it has now been found that an unexpectedly high active compound release of oestradiol and in particular norethindrone acetate can be achieved from an active compound reservoir based on ethylcellulose and tackifying resin which is provided with an unusually high proportion of plasticizer.
The patch according to the invention of the type mentioned at the outset is accordingly characterized in that the contact adhesive contains a high proportion of plasticizer.
In particular, the contact adhesive contains at least 15% by weight, preferably at least 20% by weight, of plasticizer.
The active compound-containing patch can otherwise contain emulsifiers, antioxidants and absorption enhancers.
Such a patch can be employed, in particular, for a high combined release of both oestradiol and norethindrone acetate.
REFERENCES:
patent: 4379454 (1983-04-01), Campbell et al.
patent: 4906169 (1990-03-01), Chien et al.
patent: 5306503 (1994-04-01), Muller et al.
patent: 5393529 (1995-02-01), Hoffmann et al.
patent: 5891920 (1999-04-01), Hirano et al.
patent: 32 95 258 A1 (1982-02-01), None
patent: 39 33 460 A1 (1989-10-01), None
patent: 40 20 144 A1 (1990-06-01), None
patent: 0 275 716 B1 (1987-12-01), None
Meconi Reinhold
Seibertz Frank
Ghali Isis
Hochberg D. Peter
Holt William H.
LTS Lohmann Therapie-Systeme AG
Page Thurman K.
LandOfFree
Transdermal, hormone-delivering therapeutic system does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Transdermal, hormone-delivering therapeutic system, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Transdermal, hormone-delivering therapeutic system will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2537006